Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04001855 · ClinicalTrials.gov registry record · NA
Evaluating the Effect of Bathing Additives in Atopic Dermatitis
A NA study, sponsored by University of Arizona.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04001855: Clinical Trial NA study, sponsored by University of Arizona.
NCT04001855 is a NA study that was terminated before completion, run by University of Arizona. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04001855, a NA study, was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This proposed project will be an open-label, split-arm, randomized controlled pilot study. Up to 60 patients diagnosed with atopic dermatitis (eczema) will be enrolled in the study. The purpose of this study is to understand the change in skin barrier function and skin microbial composition in patients with atopic dermatitis following dilute bleach bath/soak and dilute vinegar bath/soak.
Primary Outcome
Assess skin barrier function through measurement of transepidermal water loss (in g/m\^2h) using a commercially-available, non-invasive device (Delfin VapoMeter: http://www.delfintech.com/en/product\_information/vapometer/).
Interventions
- OTHER Dilute vinegar (acetic acid)
- OTHER Dilute bleach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
Why NCT04001855 stopped before completion
NCT04001855 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Dilute vinegar (acetic acid) is the first listed.
NCT04001855 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04001855 about?
NCT04001855 is a clinical study titled "Evaluating the Effect of Bathing Additives in Atopic Dermatitis". This proposed project will be an open-label, split-arm, randomized controlled pilot study. Up to 60 patients diagnosed with atopic dermatitis (eczema) will be enrolled in the study. The purpose of this study is to understand the change in skin barrier function and skin microbial composition in patie...
What is the current status of trial NCT04001855?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2019-07-01. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT04001855?
The interventions under investigation include: Dilute vinegar (acetic acid) (OTHER), Dilute bleach (OTHER).
Who is sponsoring clinical trial NCT04001855?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04001855's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI